| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratories of Hematopoietic Cell Kinetics [A. J. M., J. F., D. B., A. S., B. C.] and Clinical Pharmacology [T. W., K. L. V., C. W. Y.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021
We have studied the effects of thymidine (dThd) alone and in combination with 5-fluorouracil (FUra) on the survival and growth kinetics of a rapidly growing lymphoid cell line, SK-L7, in suspension culture. Continuous exposure to 10-3 M dThd increased the doubling time from 14 hr in the untreated cultures to 24 hr and reduced the cloning efficiency by about 50% after 72 hr exposure. At a 10-2 M concentration, dThd caused a progressive decline in trypan blue-excluding cells and a 98% reduction in the cloning efficiency by 72 hr, but failed to kill all the cells even after 6 days. Flow cytometric measurements of propidium iodide-stained cells showed a maximum accumulation of cells in S phase after 12 hr exposure, 74 and 85% with 10-3 and 10-2 M dThd, respectively, as compared to 61% in untreated cells. By 72 hr, the distribution of surviving cells through the cell cycle returned almost to the unperturbed state. dThd (10-4 M) and thymine (10-3 M) had no effect on the cell cycle or on growth rate. Continuous exposure to 5 x 10-7 M FUra alone prolonged the doubling time to about 24 hr and caused a delay in S-phase progression. dThd did not potentiate the cytotoxic effects of FUra, and the combined effects of these two drugs were less than additive. dThd (10-3 M) protected against the lethal effects of 5 x 10-7 M FUra and prevented the S-phase accumulation that occurred with FUra alone. dThd caused a progressive decrease in the concentration of FUra in the media by promoting the conversion of FUra to 5-fluoro-2'-deoxyuridine.
1 Supported in part by National Cancer Institute Grants CA-16757 and 19117, American Cancer Society Grant ACS-CH-6I, and the United Leukemia Fund. Presented in part at the American Association for Cancer Research Meeting, May 1979 (19).
2 To whom requests for reprints should be addressed, at Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, N. Y. 10021.
Received 10/ 4/79. Accepted 2/ 7/80.
This article has been cited by other articles:
![]() |
P. A. Hill, A. Tumber, and M. C. Meikle Multiple Extracellular Signals Promote Osteoblast Survival and Apoptosis Endocrinology, September 1, 1997; 138(9): 3849 - 3858. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |